C1.Micetich KC, Steinecker PH, Thomasma DC.

Are intravenous fluids morally required for a dying patient?

Arch Intern Med. 1983; 143: 975-8.

C2.Honma T, Yoshida S, Yoneda S, et al.

The clinical picture of terminally ill patients with lung cancer

Gan No Rinsho. 1989; 35: 891-4. Japanese.

C3.Collaud T, Rapin CH.

Dehydration in dying patients: study with physicians in French-speaking Switzerland.

J Pain Symptom Manage. 1991; 6: 230-40.

C4.Brown D, Roberts JA, Elkins TE, et al.

Hard choices: the gynecologic cancer patient's end-of-life preferences.

Gynecol Oncol. 1994; 55: 355-62.

C5.Asai A, Fukuhara S, Lo B.

Attitudes of Japanese and Japanese-American physicians towards life-sustaining treatment.

Lancet. 1995; 346: 356-9.

C6.Ahronheim JC, Morrison RS, Baskin SA, et al.

Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer.

Arch Intern Med. 1996; 156: 2094-100.

C7.Bruera E, Belzile M, Watanabe S, et al.

Volume of hydration in terminal cancer patients.

Support Care Cancer. 1996; 4: 147-50.

C8.Musgrave CF, Bartal N, Opstad J.

Intravenous hydration for terminal patients: what are the attitudes of Israeli terminal patients, their families, and their health professionals?

J Pain Symptom Manage. 1996; 12: 47-51.

C9.Meares CJ.

Primary caregiver perceptions of intake cessation in patients who are terminally Ill.

Oncol Nurs Forum. 1997; 24: 1751-7.

C10.Parkash R, Burge F.

The family's perspective on issues of hydration in terminal care.

J Palliat Care. 1997; 13: 23-7.

C11.Carmel S.

Life-sustaining treatments: what doctors do, what they want for themselves and what elderly persons want.

Soc Sci Med. 1999; 49: 1401-8.

C12.Matsushita S, Inamatsu T, Hashimoto H, et al.

Elderly outpatients' attitudes toward care in terminal stage disease

Nippon Ronen Igakkai Zasshi. 1999; 36: 45-51. Japanese.

C13.Chiu TY, Hu WY, Cheng SY, et al.

Ethical dilemmas in palliative care: a study in Taiwan.

J Med Ethics. 2000; 26: 353-7.

C14.Chiu TY, Hu WY, Chuang RB, et al.

Nutrition and hydration for terminal cancer patients in Taiwan.

Support Care Cancer. 2002; 10: 630-6.

C15.Hinkka H, Kosunen E, Metsanoja R, et al.

Factors affecting physicians' decisions to forgo life-sustaining treatments in terminal care.

J Med Ethics. 2002; 28: 109-14.

C16.Morita T, Shima Y, Adachi I, et al.

Attitudes of Japanese physicians toward terminal dehydration: a nationwide survey.

J Clin Oncol. 2002; 20: 4699-704.

C17.De Conno F, Panzeri C, Brunelli C, et al.

Palliative care in a national cancer center: results in 1987 vs. 1993 vs. 2000.

J Pain Symptom Manage. 2003; 25: 499-511.

C18.McClement SE, Degner LF, Harlos MS.

Family beliefs regarding the nutritional care of a terminally ill relative: a qualitative study.

J Palliat Med. 2003; 6: 737-48.

C19.Chiu TY, Hu WY, Chuang RB, et al.

Terminal cancer patients' wishes and influencing factors toward the provision of artificial nutrition and hydration in Taiwan.

J Pain Symptom Manage. 2004; 27: 206-14.

C20.Oh DY, Kim JE, Lee CH, et al.

Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies.

Cancer. 2004; 100: 1961-6.

C21.Tokuda Y, Nakazato N, Tamaki K.

Evaluation of end of life care in cancer patients at a teaching hospital in Japan.

J Med Ethics. 2004; 30: 264-7.